Arthur M. Cohen & Associates LLC acquired a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,659 shares of the financial services provider’s stock, valued at approximately $217,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norden Group LLC raised its position in shares of MetLife by 152.9% during the 1st quarter. Norden Group LLC now owns 8,115 shares of the financial services provider’s stock worth $601,000 after purchasing an additional 4,906 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its position in shares of MetLife by 4.5% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 142,540 shares of the financial services provider’s stock worth $10,564,000 after purchasing an additional 6,196 shares during the period. GSA Capital Partners LLP acquired a new stake in shares of MetLife during the 1st quarter worth approximately $653,000. Rehmann Capital Advisory Group raised its position in shares of MetLife by 3.5% during the 1st quarter. Rehmann Capital Advisory Group now owns 7,423 shares of the financial services provider’s stock worth $550,000 after purchasing an additional 251 shares during the period. Finally, Mediolanum International Funds Ltd acquired a new stake in shares of MetLife during the 1st quarter worth approximately $4,637,000. 89.81% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently commented on MET. Wells Fargo & Company raised their target price on MetLife from $86.00 to $92.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Citigroup raised their target price on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. TD Cowen began coverage on MetLife in a research report on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price on the stock. Keefe, Bruyette & Woods lowered their target price on MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a research report on Monday, July 8th. Finally, Barclays lowered their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.38.
MetLife Price Performance
Shares of MET traded down $0.03 during trading hours on Tuesday, hitting $77.99. 108,618 shares of the company were exchanged, compared to its average volume of 3,284,469. The company has a market capitalization of $54.62 billion, a PE ratio of 15.84, a PEG ratio of 0.71 and a beta of 1.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a fifty day simple moving average of $80.66 and a 200-day simple moving average of $74.98. MetLife, Inc. has a one year low of $58.89 and a one year high of $86.94.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.80%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- NVIDIA, Sherwin-Williams Join the Dow: What Investors Should Know
- Why Are These Companies Considered Blue Chips?
- 2 Stocks Spinning Off Divisions to Boost Shareholder Value
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.